Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status.
about
Identification of neuromedin S and its possible role in the mammalian circadian oscillator systemSensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesityNeuromedin S and UThe antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2)Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin SAnalysis of the network of feeding neuroregulators using the Allen Brain AtlasNeuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.Novel role of the anorexigenic peptide neuromedin U in the control of LH secretion and its regulation by gonadal hormones and photoperiodNeuromedin U partly mimics thyroid-stimulating hormone and triggers Wnt/β-catenin signalling in the photoperiodic response of F344 ratsNegative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin.Photoperiod regulates lean mass accretion, but not adiposity, in growing F344 rats fed a high fat dietSmall lipidated anti-obesity compounds derived from neuromedin U.Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis.Neuropeptides controlling energy balance: orexins and neuromedins.Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity.Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight.Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus.Tanycytes As Regulators of Seasonal Cycles in Neuroendocrine Function.Hypothalamic tanycytes: potential roles in the control of feeding and energy balance.Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.Identification of neuromedin U precursor-related peptide and its possible role in the regulation of prolactin release.A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States.Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake.Genome-wide SNP data unveils the globalization of domesticated pigs.Appetite-modifying actions of pro-neuromedin U-derived peptides.Isolation and characterisation of two cDNAs encoding the neuromedin U receptor from goldfish brain.Important role for the V-type H(+)-ATPase and the Golgi apparatus in the recycling of PTH/PTHrP receptor.Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway.Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice.Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis.
P2860
Q24557456-18BC2BD3-3F28-40C4-959C-0BC1D3FC157CQ24644836-DBD4063E-BC0D-45C4-A186-18D35A50D3ADQ24656108-C7BE8CD3-C955-4FDA-ABB2-9625A77C007CQ24656123-7CC45455-23E8-49DB-91AA-453277934496Q24656469-DCE58ABD-724B-446B-AD76-0F22A7C2E449Q24657212-1B7EEC5C-F962-4739-AA54-67F343D6C2FDQ24672413-F67B6D38-1D93-42ED-B1F0-AA65AF00485DQ28242546-7AFFFD3D-1F09-4ABA-96A7-DD99FF9BE2D2Q34617827-B9779AB7-70C5-467C-80BA-3CC5A18C15A5Q34812443-248EDA1A-6A52-426B-8692-A7710804AB5FQ35581235-ABEC665A-A119-4970-ABA0-7A1D1AC11AFFQ35708420-4B483545-F4B8-42BF-9762-9F5936E9FB08Q36446016-8664CAF4-9DA5-4213-89EF-CEB4F4173E28Q36531499-9F2FF7B9-BF44-4CDF-ABE6-843707C5BE06Q37000812-78A29210-94F8-4B35-9B16-E235D1341EE9Q37502658-D2C78BC3-E7C6-458F-BA08-2A5273F17CB3Q37553137-D0BAA719-D8E0-44FF-A95D-9B0A7C0DD6D7Q37691998-65828384-EFFC-4582-B1C9-4A81DF0AE46BQ38075285-6C9BBC05-9FA4-415A-B8F7-B0393720650CQ39063782-58FFDD31-69AB-4832-97BD-9EC9685733E3Q40065620-AC19FDC8-2246-43A3-A1E8-6311419FD95BQ40825183-2FE01522-9F3E-4339-88D7-3D94781E54EEQ41674388-EC55C235-D18F-4770-820E-B7362092D752Q41692195-775BFAEF-C516-4B47-9E4B-99966B4677A8Q41770325-8D1F1B8B-F0AE-4BB0-B132-1263CF4A2C5EQ44058484-FA22CBE6-FF47-451D-806B-33779E54FF91Q44854688-D972184C-0E19-44FD-8E01-46E56C24E5E6Q47035987-A0A063F0-8A9F-4923-8E1A-77E3D8211021Q47177559-6B809366-0B4B-4504-BCAF-3700888C7026Q47197295-5E809EAE-AC4F-49FC-9103-1393003EA951Q47618753-18C1C4F6-0E70-401C-A3A4-EE22CF01B6F6Q48462868-92B48EE5-771E-4F7F-B95C-42A5B4B0BDD0
P2860
Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Neuromedin U and Neuromedin U ...... effects of nutritional status.
@en
type
label
Neuromedin U and Neuromedin U ...... effects of nutritional status.
@en
prefLabel
Neuromedin U and Neuromedin U ...... effects of nutritional status.
@en
P2093
P1476
Neuromedin U and Neuromedin U ...... effects of nutritional status
@en
P2093
J G Mercer
P Fotheringham
P J Morgan
Y Turnbull
P304
P356
10.1046/J.1471-4159.2003.02079.X
P407
P577
2003-12-01T00:00:00Z